The objective of this paper is to describe three cases of combat-related posttraumatic stress disorder (PTSD), largely refractory to standard medication treatment who responded well to psychostimulant treatment. Symptoms of PTSD potentially result from chronic, stress-induced dopaminergic dysfunction in the prefrontal cortex/basal ganglia system. Psychostimulants, by their relative propensity to enhance dopamine (DA) activity within these brain regions, may have particular value in targeting this dysfunction. Evidence of dopaminergic dysfunction following chronic stress is reviewed and possible mechanism of action of psychostimulants is explored. Psychostimulants appeared to be well tolerated and beneficial in the treatment of the cases of combat-related PTSD reported. General applicability of the use of psychostimulants in combat- and non-combat-related PTSD awaits further study. The potential implications of these findings in further delineating pathophysiology and treatment in PTSD deserve further exploration.
BallengerJCDavidsonJRLecrubierYNuttDJFoaEBKesslerRC (2000) Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry61 (Suppl 5): 60–66.
2.
BlumKChenALCChenTJHBravermanERReinkingJBlumSH (2008) Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary. Theor Biol Med Model5: 24–24.
3.
BremnerJDSouthwickSMDarnellACharneyDS (1996) Chronic PTSD in Vietnam combat veterans: course of illness and substance abuse. Am J Psychiatry153: 369–375.
4.
BremnerJDStaibLHKaloupekDSouthwickSMSouferRCharneyDS (1999) Neural correlates of exposure to traumatic pictures and sound in Vietnam combat veterans with and without posttraumatic stress disorder: a positron emission tomography study. Biol Psychiatry45: 806–816.
5.
BressanRAQuarantiniLCAndreoliSBAraújoCBreenGGuindaliniC (2009) The posttraumatic stress disorder project in Brazil: neuropsychological, structural and molecular neuroimaging studies in victims of urban violence. BMC Psychiatry9: 30–30.
6.
BrewinCRAndrewsBValentineJD (2000) Meta-analysis of risk factors for posttraumatic stress disorder in trauma-exposed adults. J Consult Clin Psychol68: 748–766.
7.
BroekmanBFOlffMBoerF (2007) The genetic background to PTSD. Neurosci Biobehav Rev31: 348–362.
8.
CabibSPuglisi-AllegraS (1996) Different effects of repeated stressful experiences on mesocortical and mesolimbic dopamine metabolism. Neuroscience73: 375–380.
9.
CabibSVenturaRPuglisi-AllegraS (2002) Opposite imbalances between mesocortical and mesoaccumbens dopamine responses to stress by the same genotype depending on living conditions. Behav Brain Res129: 179–185.
10.
CharneyDS (2004) Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress. Am J Psychiatry161: 195–216.
11.
ClaesSJ (2004) Corticotropin-releasing hormone (CRH) in psychiatry: from stress to psychopathology. Ann Med36: 50–61.
12.
ComingsDEMuhlemanDGysinR (1996) Dopamine D2 receptor (DRD2) gene and susceptibility to posttraumatic stress disorder: a study and replication. Biol Psychiatry40: 368–372.
13.
Committee on Treatment of Posttraumatic Stress Disorder and Institute of Medicine (2008) Treatment of Posttraumatic Stress Disorder: An Assessment of the Evidence. Washington, DC: The National Academies Press.
14.
CreamerMMorrisPBiddleDElliottP (1999) Treatment outcome in Australian veterans with combat-related posttraumatic stress disorder: a cause for cautious optimism?J Trauma Stress12: 545–558.
15.
DalyOE (2000) The use of stimulants in the treatment of post traumatic stress disorder: case report. Hum Psychopharmacol15: 295–300.
16.
Di ChiaraG (2002) Nucleus accumbens shell and core dopamine: differential role in behavior and addiction. Behav Brain Res137: 75–114.
17.
DrevetsWCOngürDPriceJL (1998) Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders. Mol Psychiatry3: 220–226, 190–191.
18.
ElmanIArielyDMazarNAharonILaskoNBMacklinML (2005) Probing reward function in post-traumatic stress disorder with beautiful facial images. Psychiatry Res135: 179–183.
19.
EvansRWGualtieriCT (1987) Psychostimulant pharmacology in traumatic brain injury. J Head Trauma Rehabil2: 29–33.
20.
GanzelBLMorrisPAWethingtonE (2010) Allostasis and the human brain: integrating models of stress from the social and life sciences. Psychol Rev117: 134–174.
21.
GodfreyJ (2009) Safety of therapeutic methylphenidate in adults: a systematic review of the evidence. J Psychopharmacol23: 194–205.
22.
GoldsteinLERasmussonAMBunneyBSRothRH (1996) Role of the amygdala in the coordination of behavioral, neuroendocrine, and prefrontal cortical monoamine responses to psychological stress in the rat. J Neurosci16: 4787–4798.
23.
GotoYGraceAA (2005) Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior. Nat Neurosci8: 805–812.
24.
HamnerMBDiamondBI (1993) Elevated plasma dopamine in posttraumatic stress disorder: a preliminary report. Biol Psychiatry33: 304–306.
25.
IkemotoSPankseppJ (1999) The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking. Brain Res Brain Res Rev31: 6–41.
26.
InglisFMMoghaddamB (1999) Dopaminergic innervation of the amygdala is highly responsive to stress. J Neurochem72: 1088–1094.
27.
JohnsonDRRosenheckRFontanaALubinHCharneyDSouthwickS (1996) Outcome of intensive inpatient treatment for combat-related posttraumatic stress disorder. Am J Psychiatry153: 771–777.
28.
KarremanMMoghaddamB (1996) The prefrontal cortex regulates the basal release of dopamine in the limbic striatum: an effect mediated by ventral tegmental area. J Neurochem66: 589–598.
29.
KoenenKCDriverKLOscar-BermanMWolfeJFolsomSHuangMT (2001) Measures of prefrontal system dysfunction in posttraumatic stress disorder. Brain Cogn45: 64–78.
30.
KollinsSH (2003) Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient. J Clin Psychiatry64 (Suppl 11): 14–18.
31.
KollinsSH (2008) A qualitative review of issues arising in the use of psychostimulant medications in patients with ADHD and co-morbid substance use disorders. Curr Med Res Opin24: 1345–1357.
32.
LaniusRABluhmRLaniusUPainC (2006) A review of neuroimaging studies in PTSD: heterogeneity of response to symptom provocation. J Psychiatr Res40: 709–729.
33.
LedouxJEMullerJ (1997) Emotional memory and psychopathology. Philos Trans R Soc Lond B Biol Sci352: 1719–1726.
34.
LemieuxAMCoeCL (1995) Abuse-related posttraumatic stress disorder: evidence for chronic neuroendocrine activation in women. Psychosom Med57: 105–115.
35.
LevyRDuboisB (2006) Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex16: 916–928.
36.
LiberzonITaylorSFAmdurRJungTDChamberlainKRMinoshimaS (1999) Brain activation in PTSD in response to trauma-related stimuli. Biol Psychiatry45: 817–826.
37.
MaloneMAKershnerJRSwansonJM (1994) Hemispheric processing and methylphenidate effects in attention-deficit hyperactivity disorder. J Child Neurol9: 181–189.
38.
MizoguchiKYuzuriharaMIshigeASasakiHChuiDHTabiraT (2000) Chronic stress induces impairment of spatial working memory because of prefrontal dopaminergic dysfunction. J Neurosci20: 1568–1574.
39.
NicolaSMKombianSBMalenkaRC (1996) Psychostimulants depress excitatory synaptic transmission in the nucleus accumbens via presynaptic D1-like dopamine receptors. J Neurosci16: 1591–1604.
40.
PascucciTVenturaRLatagliataECCabibSPuglisi-AllegraS (2007) The medial prefrontal cortex determines the accumbens dopamine response to stress through the opposing influences of norepinephrine and dopamine. Cereb Cortex17: 2796–2804.
41.
PavicLGregurekRPetrovićRPetrovićDVardaRVukusićH (2003) Alterations in brain activation in posttraumatic stress disorder patients with severe hyperarousal symptoms and impulsive aggressiveness. Eur Arch Psychiatry Clin Neurosci253: 80–83.
SailerURobinsonSFischmeisterFPKönigDOppenauerCLueger-SchusterB (2008) Altered reward processing in the nucleus accumbens and mesial prefrontal cortex of patients with posttraumatic stress disorder. Neuropsychologia46: 2836–2844.
44.
SaladinMEBradyKTDanskyBSKilpatrickDG (1995) Understanding comorbidity between PTSD and substance use disorders: two preliminary investigations. Addict Behav20: 643–655.
45.
SchubinerH (2005) Substance abuse in patients with attention-deficit hyperactivity disorder: therapeutic implications. CNS Drugs19: 643–655.
46.
SegmanRHCooper-KazazRMacciardiFGoltserTHalfonYDobroborskiT (2002) Association between the dopamine transporter gene and posttraumatic stress disorder. Mol Psychiatry7: 903–907.
47.
ShaleyAYBonneOEthS (1996) Treatment of posttraumatic stress disorder: a review. Psychosom Med58: 165–182.
48.
VolkowNDSwansonJM (2003) Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am J Psychiatry160: 1909–1918.
49.
VolzTJ (2008) Neuropharmacological mechanisms underlying the neuroprotective effects of methylphenidate. Curr Neuropharmacol6: 379–385.
50.
VythilingamMNelsonEEScaramozzaMWaldeckTHazlettGSouthwickSM (2009) Reward circuitry in resilience to severe trauma: an fMRI investigation of resilient special forces soldiers. Psychiatry Res172: 75–77.
51.
WilensTE (2004) Impact of ADHD and its treatment on substance abuse in adults. J Clin Psychiatry65 (Suppl 3): 38–45.
52.
WilensTE (2006) Attention deficit hyperactivity disorder and substance use disorders. Am J Psychiatry163: 2059–2063.
53.
WiseRABaucoPCarlezonWAJrTrojniarW (1992) Self-stimulation and drug reward mechanisms. Ann N Y Acad Sci654: 192–198.
54.
YoungRMLawfordBRNobleEPKannBWilkieARitchieT (2002) Harmful drinking in military veterans with post-traumatic stress disorder: association with the D2 dopamine receptor A1 allele. Alcohol Alcohol37: 451–456.
